The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
NCT01761825 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2013-01-07
Summary
The purpose of this study is to determine whether Ivabradine is an effective treatment for postural tachycardia syndrome.
Conditions
- Postural Tachycardia Syndrome
Interventions
- DRUG
-
ivabradine
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-02-28
More Related Trials
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
NCT01000350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
NCT01029223 ·Status: WITHDRAWN ·Phase: PHASE4
-
Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease
NCT01039389 ·Status: COMPLETED ·Phase: NA
-
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
NCT02171988 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
NCT01022463 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
NCT04285736 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia
NCT00390546 ·Status: COMPLETED ·Phase: PHASE3
-
Pulse Reduction On Beta-blocker and Ivabradine Therapy
NCT02973594 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals
NCT00825123 ·Status: TERMINATED ·Phase: PHASE4
-
Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock
NCT06742164 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
POTS Adrenergic Ab (CIHR Aims #1&2)
NCT02673996 ·Status: RECRUITING
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT04072835 ·Status: COMPLETED ·Phase: PHASE3
-
Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure
NCT02086422 ·Status: UNKNOWN ·Phase: NA
-
Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers
NCT02264002 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker
NCT03245996 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
NCT03464019 ·Status: TERMINATED ·Phase: PHASE3
-
PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery
NCT04436016 ·Status: COMPLETED ·Phase: PHASE4
-
Autonomic Determinants of POTS - Pilot1
NCT04050410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of Efficacy of Ivabradine Versus Metoprolol
NCT01755663 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Exercise in OI
NCT00770484 ·Status: COMPLETED ·Phase: NA
-
Anxiety and Vagal Control of the Heart in Coronary Disease
NCT00006311 ·Status: COMPLETED
-
Ivabradine in Cirrhotic Cardiomyopathy
NCT04111133 ·Status: RECRUITING ·Phase: NA
-
A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
NCT01263197 ·Status: COMPLETED ·Phase: PHASE1
-
Dobutamine on the Cardiac Conduction System
NCT04249258 ·Status: COMPLETED ·Phase: EARLY_PHASE1